Sperimentazione in fase di reclutamento = ; Sperimentazione in corso = ; Sperimentazione conclusa = ; Finanziato da un ente associato a IRDiRC = ; Membro di una ERN =

Sperimentazioni cliniche nazionali

PAESI BASSI

Zuid-Holland
LEIDEN

Exploratory study on the local dystrophin production restoring effect and safety and tolerability of a single intramuscular dose of antisense oligoribonucleotide PRO051 in Duchenne muscular dystrophy patients.

LUMC - Leids Universitair Medisch Centrum

Polikliniek Neurologie

Ulteriori dettagli

PAESI BASSI

Zuid-Holland
LEIDEN

A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess the Effect, Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Doses of PRO044 in Patients With Duchenne Muscular Dystrophy

LUMC - Leids Universitair Medisch Centrum

Polikliniek Neurologie

Ulteriori dettagli